Effects of pharmacological agents on the lifespan phenotype of Drosophila DJ-1β mutants

Gene

Volumn 462, Issue 1-2, 2010, Pages 26-33

  Lavara Culebras, Eusebio ^a   Muñoz Soriano, Verónica ^a   Gómez Pastor, Rocío ^b   Matallana, Emilia ^a,b   Paricio, Nuria ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Tocopherol; DJ 1; L DOPA; Melatonin; Oxidative stress; Parkinson's disease; Pergolide; SK F 38393; Vitamin C

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ANTIPARKINSON AGENT; ASCORBIC ACID; BUTYLCRESOL; CATALASE; DJ 1 PROTEIN; DJ 1BETA PROTEIN; LEVODOPA; MELATONIN; PERGOLIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DROSOPHILA; ENZYME ACTIVITY; FEMALE; GENE FUNCTION; GENE MUTATION; LIFESPAN; LIPID PEROXIDATION; MALE; MUTANT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTIOXIDANTS; BRAIN; DOPAMINE; DROSOPHILA; MUTATION; OXIDATIVE STRESS; PARAQUAT; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PHENOTYPE; REACTIVE OXYGEN SPECIES;

MUS;

EID: 77954144175     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2010.04.009     Document Type: Article

References (55)

1. Anisimov V.N., Popovich I.G., Zabezhinski M.A., Anisimov S.V., Vesnushkin G.M., Vinogradova I.A. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim. Biophys. Acta 2006, 1757:573-589.
2. Bahadorani S., Bahadorani P., Phillips J.P., Hilliker A.J. The effects of vitamin supplementation on Drosophila life span under normoxia and under oxidative stress. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63:35-42.
3. Bahadorani S., Hilliker A.J. Antioxidants cannot suppress the lethal phenotype of a Drosophila model of Huntington's disease. Genome 2008, 51:392-395.
4. Betarbet R., et al. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol. Dis. 2006, 22:404-420.
5. Blackinton J., et al. Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. Neurosci Lett. 2009, 4521:8-11.
6. Bonifati V., et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
7. Bonilla E., Medina-Leendertz S., Díaz S. Extension of life span and stress resistance of Drosophila melanogaster by long-term supplementation with melatonin. Exp. Gerontol. 2002, 37:629-638.
8. Bonilla E., Medina-Leendertz S., Villalobos V., Molero L., Bohorquez A. Paraquat-induced oxidative stress in Drosophila melanogaster: effects of melatonin, glutathione, serotonin, minocycline, lipoic acid and ascorbic acid. Neurochem. Res. 2006, 31:1425-1432.
9. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Meth. Enzymol. 1978, 52:302-310.
10. Canet-Aviles R.M., et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA 2004, 101:9103-9108.
11. Chen L., et al. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J. Biol. Chem. 2005, 280:21418-21426.
12. Choi J., et al. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 2006, 281:10816-10824.
13. Coulom H., Birman S. Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J. Neurosci. 2004, 24:10993-10998.
14. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
15. Dias-Santagata D., Fulga T.A., Duttaroy A., Feany M.B. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Invest. 2007, 117:236-245.
16. Draper H.H., Philbrick D.P., Agarwal S., Philips J.P. Avid uptake of linoleic acid and vitamin E by Drosophila melanogaster. Nutr. Res. 2000, 20:113-120.
17. Faust K., Gehrke S., Yang Y., Yang L., Beal M.F., Lu B. Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease. BMC Neurosci. 2009, 10:109.
18. Goldberg M.S., et al. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 2005, 45:489-496.
19. Gomeza J., et al. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc. Natl Acad. Sci. USA 1999, 96:10483-10488.
20. Greene J.C., Whitworth A.J., Kuo I., Andrews L.A., Feany M.B., Pallanck L.J. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4078-4083.
21. Gruenewald C., Botella J.A., Bayersdorfer F., Navarro J.A., Schneuwly S. Hyperoxia-induced neurodegeneration as a tool to identify neuroprotective genes in Drosophila melanogaster. Free Radical Biol. Med. 2009, 46:1668-1676.
22. Hong J.H., et al. Effects of vitamin E on oxidative stress and membrane fluidity in brain of streptozotocin-induced diabetic rats. Clin. Chim. Acta 2004, 340:107-115.
23. Izmaylov D.M., Obukhova L.K. Geroprotector effectiveness of melatonin: investigation of lifespan of Drosophila melanogaster. Mech. Ageing Dev. 1999, 106:233-240.
24. Jakubowski W., Bilinski T., Bartosz G. Oxidative stress during aging of stationary cultures of the yeast Saccharomyces cerevisiae. Free Radical Biol. 2000, 28:659-664.
25. Karasek M. Melatonin, human aging, and age related diseases. Exp. Gerontol. 2004, 39:1723-1729.
26. Lang A.E., Lozano A.M. Parkinson's disease. First of two parts. N Engl J. Med. 1998, 339:1044-1053.
27. Lavara-Culebras E., Paricio N. Drosophila DJ-1 mutants are sensitive to oxidative stress and show reduced lifespan and motor deficits. Gene 2007, 400:158-165.
28. Lee Y., et al. Loss of spastic paraplegia gene atlastin induces age-dependent death of dopaminergic neurons in Drosophila. Neurobiol. Aging 2008, 29:84-94.
29. Lockrow J., Prakasam A., Huang P., Bimonte-Nelson H., Sambamurti K., Granholm A.C. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp. Neurol. 2009, 216:278-289.
30. Magwere T., West M., Riyahi K., Murphy M.P., Smith R.A., Partridge L. The effects of exogenous antioxidants on lifespan and oxidative stress resistance in Drosophila melanogaster. Mech. Ageing Dev. 2006, 127:356-370.
31. Menzies F.M., Yenisetti S.C., Min K.T. Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr. Biol. 2005, 15:1578-1582.
32. Meulener M., et al. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr. Biol. 2005, 15:1572-1577.
33. Meulener M., Xu K., Thomson L., Ischiropoulos H., Bonini N.M. Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc. Natl Acad. Sci. USA 2006, 103:12517-12522.
34. Nagakubo D., et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun. 1997, 231:509-513.
35. Nakashima H., et al. Effects of alpha-tocopherol on an animal model of tauopathies. Free Radical Biol. Med. 2004, 37:176-186.
36. Park J., Kim S.Y., Cha G.H., Lee S.B., Kim S., Chung J. Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 2005, 361:133-139.
37. Pendleton R.G., Samler L., Kaiser C., Ridley P.T. Studies on renal dopamine receptors with a new agonist. Eur. J. Pharmacol. 1978, 51:19-28.
38. Pendleton R.G., Parvez F., Sayed M., Hillman R. Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J. Pharmacol. Exp. Ther. 2002, 300:91-96.
39. Pratico D., Tangirala R.K., Rader D.J., Rokach J., FitzGerald C.A. Vitamin E suppresses generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat. Med. 1998, 4:1189-1192.
40. Radad K., Gille G., Rausch W.D. Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease. Pharmacol. Rep. 2005, 57:701-712.
41. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E: protective role of a Janus molecule. FASEB J. 2001, 15:2314-2325.
42. Ricciarelli R., Argellati F., Pronzato M.A., Domenicotti C. Vitamin E and neurodegenerative diseases. Mol. Aspects Med. 2007, 28:591-606.
43. Schultz J.B. Update on the pathogenesis of Parkinson's disease. J. Neurol. 2008, 255(Suppl 5):3-7.
44. Standaert D.J., Young A.B. Treatment of central nervous system degeneration disorders. Goodman & Gilman's The Pharmacological Basis of Therapeutics 1996, 503-519. McGraw-Hill Companies, New York. G.J. Harman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Gilman (Eds.).
45. Tucker J.M., Townsend D.M. Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed. Pharmacother. 2005, 59:380-387.
46. 2. Eur. J. Pharmacol. 2002, 434:17-20.
47. Van der Brug M.P., et al. RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc. Natl Acad. Sci. USA 2008, 105:10244-10249.
48. Walker D.W., et al. Hypersensitivity to oxygen and shortened lifespan in a Drosophila mitochondrial complex II mutant. Proc. Natl Acad. Sci. USA 2006, 103:16382-16387.
49. Wang D., et al. Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc. Natl Acad. Sci. USA 2006, 103:13520-13525.
50. Wakamatsu M., Iwata S., Funakoshi T., Yoshimoto M. Dopamine receptor agonists reverse behavioral abnormalities of alfa-synuclein transgenic mouse, a new model of Parkinson's disease. J. Neurosci. Res. 2008, 86:640-646.
51. Yang Y., et al. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl Acad. Sci. USA 2005, 102:13670-13675.
52. Yang Y., Wu Z., Kuo Y.M., Zhou B. Dietary rescue of fumble-a Drosophila model for pantothenate-kinase-associated neurodegeneration. J. Inherit. Metab. Dis. 2005, 28:236-245.
53. Zaidi S.M., Banu N. Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain. Clin. Chim. Acta 2004, 340:229-233.
54. Zhong N., Xu J. Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1α: regulation by SUMOylation and oxidation. Hum. Mol. Genet. 2008, 17:3357-3367.
55. Zou S., et al. Comparative approaches to facilitate the discovery of prolongevity interventions: effects of tocopherols on lifespan of three invertebrate species. Mech. Ageing Dev. 2007, 128:222-226.